AllianceBernstein
AURA icon

AllianceBernstein’s Aura Biosciences AURA Stock Holding History

AllianceBernstein’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Buy
52,760
+11,100
+27% +$79.4K ﹤0.01% 2909
2026
Q1 		$227K Hold
41,660
– – ﹤0.01% 2996
2025
Q4 		$227K Hold
41,660
– – ﹤0.01% 3016
2025
Q3 		$257K Hold
41,660
– – ﹤0.01% 2994
2025
Q2 		$261K Buy
41,660
+17,840
+75% +$104K ﹤0.01% 2982
2025
Q1 		$140K Hold
23,820
– – ﹤0.01% 3013
2024
Q4 		$196K Hold
23,820
– – ﹤0.01% 3027
2024
Q3 		$212K Buy
23,820
+1,450
+6% +$12.4K ﹤0.01% 3024
2024
Q2 		$169K Buy
22,370
+9,440
+73% +$69.1K ﹤0.01% 3059
2024
Q1 		$102K Hold
12,930
– – ﹤0.01% 3029
2023
Q4 		$115K Buy
12,930
+2,230
+21% +$18.9K ﹤0.01% 3055
2023
Q3 		$96K Buy
10,700
+570
+6% +$6.13K ﹤0.01% 3075
2023
Q2 		$125K Buy
+10,130
New +$108K ﹤0.01% 3058

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

AllianceBernstein's AURA Position: Q2 2026 in Review

AllianceBernstein increased its Aura Biosciences (AURA) stake by 27% in Q2 2026, buying an estimated $79.4K and bringing the position to 52,760 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #2909.

AllianceBernstein first reported a position in AURA in Q2 2023 and has held it in 13 quarters since. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • AllianceBernstein held 52,760 shares of Aura Biosciences worth $353K as of Q2 2026.
  • AllianceBernstein bought 11,100 Aura Biosciences shares in Q2 2026, an estimated $79.4K.
  • Aura Biosciences made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2909 holding.
  • AllianceBernstein first reported a position in Aura Biosciences in Q2 2023 and has held it in 13 quarters since.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.